FDA Adverse Event Death Summary report: N

SPRINT QUATTRO SECURE

MDR report key: 3002453 · Received March 13, 2013

Report

Report Number
2649622-2013-02524
Event Type
Death
Date Received
March 13, 2013
Date of Event
February 11, 2013
Report Date
February 11, 2013
Manufacturer
MPRI
Product Code
NVY
PMA / PMN Number
P920015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. CONCOMITANT PRODUCT: 5076 IMPLANTABLE PACING LEAD 2013 (B)(6). (B)(4). THE LEAD WAS NOT RETURNED TO THE MANUFACTURER AND WILL NOT BE EVALUATED.

Additional Manufacturer Narrative · 1

CORRECTED INFORMATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT CODED AND DIED AFTER THE IMPLANT OF AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DUE TO VENTRICULAR FIBRILLATION ARREST.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
105063 SPRINT QUATTRO SECURE DRUG-ELUTING PERMANENT DEFIBRILLATOR ELECTRODES NVY MPRI 6947M62

Patients

Seq Age Sex Outcome Treatment
1 00069 YR Death (B)(4) IMPLANTABLE CARDIOVERTER DEFIBRILLATOR